56 related articles for article (PubMed ID: 16625091)
1. Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status.
Chui MH; Murali R; Soslow RA; Matrai C; Xing D; Vang R
Int J Gynecol Pathol; 2023 Sep; 42(5):472-481. PubMed ID: 36867514
[TBL] [Abstract][Full Text] [Related]
2. Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study.
Baba T; Koshiyama M; Kagabu M; Mikami Y; Minamiguchi S; Moritani S; Ishikawa M; Okamoto A; Terao Y; Nakanishi T; Katabuchi H; Tokunaga H; Satoh T; Konishi I; Yaegashi N
Int J Clin Oncol; 2023 Oct; 28(10):1411-1420. PubMed ID: 37526805
[TBL] [Abstract][Full Text] [Related]
3. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.
Akçay A; Peker AA; Oran Z; Toprak H; Toluk Ö; Balsak S; Badur BA; Gültekin MA
Abdom Radiol (NY); 2024 Jan; 49(1):229-236. PubMed ID: 37857912
[TBL] [Abstract][Full Text] [Related]
4. [Borderline ovarian tumours: CNGOF Guidelines for clinical practice - Biopathology of ovarian borderline tumors].
Eymerit-Morin C; Brun JL; Vabret O; Devouassoux-Shisheboran M
Gynecol Obstet Fertil Senol; 2020 Sep; 48(9):629-645. PubMed ID: 32422414
[TBL] [Abstract][Full Text] [Related]
5. Serous Borderline Ovarian Epithelial Type Tumors of Testis in A Young Man with Only Mass Resection: A Case Report.
Rahimi M; Moradi Y; Khaleghimehr F
Iran J Pathol; 2023; 18(4):476-479. PubMed ID: 38024554
[TBL] [Abstract][Full Text] [Related]
6. Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression.
Schweizer L; Krishnan R; Shimizu A; Metousis A; Kenny H; Mendoza R; Nordmann TM; Rauch S; Kelliher L; Heide J; Rosenberger FA; Bilecz A; Borrego SN; Strauss MT; Thielert M; Rodriguez E; Müller-Reif JB; Chen M; Yamada SD; Mund A; Lastra RR; Mann M; Lengyel E
medRxiv; 2023 Nov; ():. PubMed ID: 38014221
[TBL] [Abstract][Full Text] [Related]
7. Paratubal serous borderline tumor in an 85 years old woman: A case report.
Mehawej J; El Helou N; Wang L; Mhawech-Fauceglia P
Gynecol Oncol Rep; 2020 May; 32():100559. PubMed ID: 32258331
[TBL] [Abstract][Full Text] [Related]
8. Serous borderline tumor of the ovary with isolated cardiophrenic lymph node spread at diagnosis.
St Laurent JD; Gockley AA; Cathcart AM; Baranov E; Kolin DL; Worley MJ
Gynecol Oncol Rep; 2020 Aug; 33():100586. PubMed ID: 32529019
[TBL] [Abstract][Full Text] [Related]
9. A guided tour of selected issues pertaining to metastatic carcinomas involving or originating from the gynecologic tract.
Soslow RA; Murali R
Semin Diagn Pathol; 2018 Mar; 35(2):95-107. PubMed ID: 29248205
[TBL] [Abstract][Full Text] [Related]
10. Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany.
Coumbos A; Sehouli J; Chekerov R; Schaedel D; Oskay-Oezcelik G; Lichtenegger W; Kuehn W;
Br J Cancer; 2009 Jun; 100(11):1731-8. PubMed ID: 19436295
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
[TBL] [Abstract][Full Text] [Related]
12. Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion.
Ahn G; Folkins AK; McKenney JK; Longacre TA
Am J Surg Pathol; 2016 Sep; 40(9):1165-76. PubMed ID: 27487741
[TBL] [Abstract][Full Text] [Related]
13. Pathologic findings in eight cases of ovarian serous borderline tumors, three with foci of serous carcinoma, that preceded death or morbidity from invasive carcinoma.
Lee KR; Castrillon DH; Nucci MR
Int J Gynecol Pathol; 2001 Oct; 20(4):329-34. PubMed ID: 11603215
[TBL] [Abstract][Full Text] [Related]
14. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma.
Rollins SE; Young RH; Bell DA
Am J Surg Pathol; 2006 Apr; 30(4):457-62. PubMed ID: 16625091
[TBL] [Abstract][Full Text] [Related]
15. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.
Prat J; De Nictolis M
Am J Surg Pathol; 2002 Sep; 26(9):1111-28. PubMed ID: 12218568
[TBL] [Abstract][Full Text] [Related]
16. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
